Loading…

Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species

Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or parac...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in veterinary science 2022-03, Vol.9, p.806069-806069
Main Authors: Uberti, Benjamin, Plaza, Anita, Henríquez, Claudio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3
cites cdi_FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3
container_end_page 806069
container_issue
container_start_page 806069
container_title Frontiers in veterinary science
container_volume 9
creator Uberti, Benjamin
Plaza, Anita
Henríquez, Claudio
description Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates , cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.
doi_str_mv 10.3389/fvets.2022.806069
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a546a7b386f741259edf61745235ec93</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a546a7b386f741259edf61745235ec93</doaj_id><sourcerecordid>2646950828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3</originalsourceid><addsrcrecordid>eNpVkctqGzEUhkVpaYKTB-imaNmNHd1H2hSK6cXg0oDbtdBojhylMyNXGhv89pXjJCSrcziX70j_j9AHShaca3MTDjCVBSOMLTRRRJk36JIx08xpo8zbF_kFui7lnhBCpWi4Ju_RBZe8YVKSSzTeZpj7NHZximmM4xZvpuwm2EYoOKSMf0KB0d8dB9efWqnGm80EA15C3xccR7waQ--GwU0pH_HyCVVwCngdD1Cm5P_izQ58RV6hd8H1Ba4f4wz9-fb19_LHfP3r-2r5ZT333MhpToVqWydbCIwz0EI4QlsAxjtmTP295joApa5rjFQtbYLQDGQXjPfeiC7wGVqduV1y93aX4-Dy0SYX7UMh5a11eYq-B-ukUK5puVahEZRJA11QtBGScQm-Xpuhz2fWbt8O0HkYq0L9K-jrzhjv7DYdrDaNEERUwKdHQE7_9lUQO8Tiq3xuhLQvlimhjCSa6TpKz6M-p1IyhOczlNiT7fbBdnuy3Z5trzsfX77veePJZP4fVMWsQQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2646950828</pqid></control><display><type>article</type><title>Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species</title><source>PubMed Central</source><creator>Uberti, Benjamin ; Plaza, Anita ; Henríquez, Claudio</creator><creatorcontrib>Uberti, Benjamin ; Plaza, Anita ; Henríquez, Claudio</creatorcontrib><description>Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates , cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.</description><identifier>ISSN: 2297-1769</identifier><identifier>EISSN: 2297-1769</identifier><identifier>DOI: 10.3389/fvets.2022.806069</identifier><identifier>PMID: 35372550</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>hypoxia ; inflammation ; livestock animals ; mesenchymal stem cells ; mesenchymal stromal cells ; pre-conditioning ; Veterinary Science</subject><ispartof>Frontiers in veterinary science, 2022-03, Vol.9, p.806069-806069</ispartof><rights>Copyright © 2022 Uberti, Plaza and Henríquez.</rights><rights>Copyright © 2022 Uberti, Plaza and Henríquez. 2022 Uberti, Plaza and Henríquez</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3</citedby><cites>FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974404/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974404/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35372550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uberti, Benjamin</creatorcontrib><creatorcontrib>Plaza, Anita</creatorcontrib><creatorcontrib>Henríquez, Claudio</creatorcontrib><title>Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species</title><title>Frontiers in veterinary science</title><addtitle>Front Vet Sci</addtitle><description>Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates , cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.</description><subject>hypoxia</subject><subject>inflammation</subject><subject>livestock animals</subject><subject>mesenchymal stem cells</subject><subject>mesenchymal stromal cells</subject><subject>pre-conditioning</subject><subject>Veterinary Science</subject><issn>2297-1769</issn><issn>2297-1769</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctqGzEUhkVpaYKTB-imaNmNHd1H2hSK6cXg0oDbtdBojhylMyNXGhv89pXjJCSrcziX70j_j9AHShaca3MTDjCVBSOMLTRRRJk36JIx08xpo8zbF_kFui7lnhBCpWi4Ju_RBZe8YVKSSzTeZpj7NHZximmM4xZvpuwm2EYoOKSMf0KB0d8dB9efWqnGm80EA15C3xccR7waQ--GwU0pH_HyCVVwCngdD1Cm5P_izQ58RV6hd8H1Ba4f4wz9-fb19_LHfP3r-2r5ZT333MhpToVqWydbCIwz0EI4QlsAxjtmTP295joApa5rjFQtbYLQDGQXjPfeiC7wGVqduV1y93aX4-Dy0SYX7UMh5a11eYq-B-ukUK5puVahEZRJA11QtBGScQm-Xpuhz2fWbt8O0HkYq0L9K-jrzhjv7DYdrDaNEERUwKdHQE7_9lUQO8Tiq3xuhLQvlimhjCSa6TpKz6M-p1IyhOczlNiT7fbBdnuy3Z5trzsfX77veePJZP4fVMWsQQ</recordid><startdate>20220316</startdate><enddate>20220316</enddate><creator>Uberti, Benjamin</creator><creator>Plaza, Anita</creator><creator>Henríquez, Claudio</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220316</creationdate><title>Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species</title><author>Uberti, Benjamin ; Plaza, Anita ; Henríquez, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>hypoxia</topic><topic>inflammation</topic><topic>livestock animals</topic><topic>mesenchymal stem cells</topic><topic>mesenchymal stromal cells</topic><topic>pre-conditioning</topic><topic>Veterinary Science</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uberti, Benjamin</creatorcontrib><creatorcontrib>Plaza, Anita</creatorcontrib><creatorcontrib>Henríquez, Claudio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in veterinary science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uberti, Benjamin</au><au>Plaza, Anita</au><au>Henríquez, Claudio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species</atitle><jtitle>Frontiers in veterinary science</jtitle><addtitle>Front Vet Sci</addtitle><date>2022-03-16</date><risdate>2022</risdate><volume>9</volume><spage>806069</spage><epage>806069</epage><pages>806069-806069</pages><issn>2297-1769</issn><eissn>2297-1769</eissn><abstract>Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates , cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35372550</pmid><doi>10.3389/fvets.2022.806069</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2297-1769
ispartof Frontiers in veterinary science, 2022-03, Vol.9, p.806069-806069
issn 2297-1769
2297-1769
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a546a7b386f741259edf61745235ec93
source PubMed Central
subjects hypoxia
inflammation
livestock animals
mesenchymal stem cells
mesenchymal stromal cells
pre-conditioning
Veterinary Science
title Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A15%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pre-conditioning%20Strategies%20for%20Mesenchymal%20Stromal/Stem%20Cells%20in%20Inflammatory%20Conditions%20of%20Livestock%20Species&rft.jtitle=Frontiers%20in%20veterinary%20science&rft.au=Uberti,%20Benjamin&rft.date=2022-03-16&rft.volume=9&rft.spage=806069&rft.epage=806069&rft.pages=806069-806069&rft.issn=2297-1769&rft.eissn=2297-1769&rft_id=info:doi/10.3389/fvets.2022.806069&rft_dat=%3Cproquest_doaj_%3E2646950828%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-146bba5bef232e844a01bee23d299338838fe11ad7956b17f482e5df9ccc94df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2646950828&rft_id=info:pmid/35372550&rfr_iscdi=true